International Business News - Adolor http://www.ibtimes.com All articles are copyrighted by IBTimes.com 400 100 http://www.ibtimes.com/ http://www.ibtimes.com/images/top_logo_ibt2_3.gif Adolor Corp. said Thursday the Food and Drug Administration has lifted its clinical hold on the company's Entereg drug in chronically constipated patients taking opioid pain drugs. http://www.ibtimes.com/articles/20080703/fda-lifts-clinical-hold-on-adolor-bowel-drug.htm Thu, 03 Jul 2008 08:33:09 EDT Biopharmaceutical company Adolor Corp. said Friday it appointed Stephen W. Webster as chief financial officer, effective on or about June 30. Webster succeeds Thomas Hess, who has resigned to pursue another business opportunity. http://www.ibtimes.com/articles/20080613/adolor-appoints-stephen-w-webster-as-cfo.htm Fri, 13 Jun 2008 15:18:31 EDT Shares of Adolor Corp. climbed to a fresh annual high Wednesday, after regulators approved its constipation treatment Entereg, but analysts were divided on sales prospects for the drug. http://www.ibtimes.com/articles/20080521/out-of-the-gate-adolor-jumps-on-entereg-approval.htm Wed, 21 May 2008 10:11:16 EDT Adolor Corp. said Friday that the Food and Drug Administration won't be making a decision on approval of the company's Entereg drug for post-surgery bowel blockage by Saturday, the scheduled action date. http://www.ibtimes.com/articles/20080509/adolor-says-fda-delays-decision-on-bowel-drug-entereg.htm Fri, 09 May 2008 08:50:56 EDT The Food and Drug Administration said Friday it will take up to three additional months to make a decision on Adolor Corp. and GlaxoSmithKline's anti-constipation drug candidate Entereg. http://www.ibtimes.com/articles/20080208/adolor-glaxo-drug-review-postponed.htm Fri, 08 Feb 2008 16:34:40 EST Government experts are scheduled to vote Wednesday on whether a drug made by Adolor Corp. should be approved in the U.S. to treat severe constipation following surgery. http://www.ibtimes.com/articles/20080123/ahead-of-the-bell-adolor-drug-reviewed.htm Wed, 23 Jan 2008 06:33:18 EST Adolor Corp. said Friday the Food and Drug Administration approved clinical trials for the biotechnology company's pain treatment candidate ADL5747. The company said it plans to start a Phase I, or early stage, study on the drug candidate in the first quarter. The drug is the second to enter development as part of a partnership with Pfizer Inc. The companies are already studying pain drug candidate ADL5859 in a mid-stage clinical trial. http://www.ibtimes.com/articles/20071228/adolor-pain-drug-study-gets-fda-approval.htm Fri, 28 Dec 2007 08:55:26 EST